Zai Ding Pharmaceuticals' Ketrozole has been approved for the treatment of schizophrenia in China.

On December 23, Reignwood Pharmtech announced that the China National Medical Products Administration has approved the new drug marketing application for Fluoxetine Quetiapine Capsules, used for treating adult schizophrenia.